2011International Journal of Pathology and Clinical MedicineRequires access

Uterine smooth muscle tumors:A clinicopathologic analysis of 246 cases

Ning Zhang

Open publisher page 0 citations

Abstract

Objective To investigate the clinicopathological features of uterine smooth muscle tumors.Methods Clinical and pathological data from 246 cases of uterine smooth muscle tumors were analyzed retrospectively.Results The peak time for incidence of uterine smooth muscle tumors is in patients with 40 ~ 50 years old.Uterine smooth muscle tumors could co-exist with other diseases such as endometrial hyperplasia,adenomyosis,all kinds of benign or malignant pathological change of cervix and ovary.Among 246 cases,the percentage for usual leiomyoma,special leiomyoma,leiomyosarcoma,and smooth muscle tumor with uncertain malignant potential is 91.4%,6.9%,0.8%,and 0.8%,respectively.Conclusion Uterine smooth muscle tumors is gynecological common tumors.Coagulative(tumor) necrosis,severe nuclear atypia,and high mitotic rate are major criterion for diagnosis of benign and malignant tumors.Multiple clinicopathologic factors should be analyzed to predict biological behavior of uterine smooth muscle tumors.

About this research paper

What this paper is about

Objective To investigate the clinicopathological features of uterine smooth muscle tumors.Methods Clinical and pathological data from 246 cases of uterine smooth muscle tumors were analyzed retrospectively.Results The peak time for incidence of uterine smooth muscle tumors is in patients with 40 ~ 50 years old.Uterine smooth muscle tumors could co-exist with other diseases such as endometrial hyperplasia,adenomyosis,all kinds of benign or malignant pathological change of cervix and ovary.Among 246 cases,the percentage for usual leiomyoma,special leiomyoma,leiomyosarcoma,and smooth muscle tumor with uncertain malignant potential is 91.4%,6.9%,0.8%,and 0.8%,respectively.Conclusion Uterine smooth muscle tumors is gynecological common tumors.Coagulative(tumor) necrosis,severe nuclear atypia,and high mitotic rate are major criterion for diagnosis of benign and malignant tumors.Multiple clinicopathologic factors should be analyzed to predict biological behavior of uterine smooth muscle tumors.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinicopathological features of uterine smooth muscle tumors.Methods Clinical and pathological data from 246 cases of uterine smooth muscle tumors were analyzed retrospectively.Results The peak time for incidence of uterine smooth muscle tumors is in patients with 40 ~ 50 years old.Uterine smooth muscle tumors could co-exist with other diseases such as endometrial hyperplasia,adenomyosis,all kinds of benign or malignant pathological change of cervix and ovary.Among 246 cases,the percentage for usual leiomyoma,special leiomyoma,leiomyosarcoma,and smooth muscle tumor with uncertain malignant potential is 91.4%,6.9%,0.8%,and 0.8%,respectively.Conclusion Uterine smooth muscle tumors is gynecological common tumors.Coagulative(tumor) necrosis,severe nuclear atypia,and high mitotic rate are major criterion for diagnosis of benign and malignant tumors.Multiple clinicopathologic factors should be analyzed to predict biological behavior of uterine smooth muscle tumors.

Key concepts: Smooth Muscle Tumor, Leiomyosarcoma, Leiomyoma, Medicine, Pathology, Atypia, Adenomyosis, Coagulative necrosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Uterine smooth muscle tumors:A clinicopathologic analysis of 246 cases — Research Paper | ScholarLens